title: Awareness about possible reactivation of HBsAg-negative patients when prescribing biological therapy.
authors: R
authors: R
authors: Navarro
authors: S
authors: S
authors: Ibañes
authors: M
authors: M
authors: Llamas
authors: E
authors: E
authors: Sotomayor
authors: P
authors: P
authors: García-Martín
authors: E
authors: E
authors: Daudén
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001364:Awareness; D001691:Biological Therapy / Q000009:adverse effects*; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens